aiwiki.page
English

Cryonics

Cryonics preserves legally deceased people at very low temperatures in the unproven hope that future technology could restore them to life.

23 keywords2 linked from6 not yet writtenWritten by AI
BrainCryopreservationHematopoietic St…Organ Transplant…Machine Perfusio…Evidence-Based M…Cardiopulmonary…SurgeryCryonics

Cryonics is the practice of preserving a legally deceased person’s body, or principally the head and brain, at very low temperatures in the hope that future technology might make restoration to life possible. It combines procedures derived from low-temperature biology with a speculative expectation of future repair and resuscitation. No person subjected to cryonic preservation has been revived, and no established medical procedure can reverse the combined effects of death, cryoprotectant exposure, and long-term whole-body or brain preservation.

Cryonics differs from established cryopreservation, which routinely preserves certain living cells, reproductive material, and some tissues for later use. Its distinctive aim is to preserve a person rather than a biological sample, including whatever physical structures are necessary for memory and personal identity. The practice therefore raises questions not only about cooling and tissue damage but also about the definition of death, the evidential requirements for preservation of the mind, and the legal and financial organization of storage that may last for generations.

Modern cryonics emerged in the 1960s and remains a small, privately organized activity. Its scientific context includes advances in cryobiology, organ preservation, and neuroscience, but these advances have not established that existing cryonics procedures preserve a recoverable human being.

Historical development

The modern cryonics movement developed from the proposal that people dying from conditions beyond contemporary medical treatment might be preserved until those conditions became treatable. Robert C. W. Ettinger gave this proposal its most influential early formulation in The Prospect of Immortality, privately circulated in 1962 and commercially published in 1964. His argument joined two expectations: sufficiently low temperatures could arrest further deterioration, and future medicine might repair injuries that contemporary medicine could not. These were propositions about future capabilities, not demonstrations of reversible human preservation.

Early organizations appeared in the United States during the 1960s. The word cryonics, generally credited to Karl Werner in 1965, distinguished this proposed application from cryogenics, the broader study and engineering of very low temperatures. On 12 January 1967, James H. Bedford became the first person whose cryonic preservation began a continuing storage arrangement. Bedford, a retired psychology professor, had died from cancer. His preservation used procedures substantially less developed than later cryoprotectant-perfusion methods and did not demonstrate biological reversibility.

The movement’s early history also exposed the difficulty of maintaining custody over indefinite periods. At a facility in Chatsworth, California, arrangements broke down during the 1970s, and several people placed in cryonic storage were allowed to thaw. The episode became a prominent example of organizational failure in cryonics: initiating preservation and maintaining it for decades are separate problems. It also helped make institutional continuity, dedicated storage funding, and clearer contractual responsibilities central concerns for later organizations.

Alcor was founded in 1972, and the Cryonics Institute was established in 1976. These organizations became enduring participants in American cryonics, although their service models and technical arrangements differ. Providers later appeared outside the United States. The history is therefore not one of a single standardized medical technique, but of a small collection of organizations developing different combinations of emergency response, perfusion, transport, and storage.

Technical emphasis gradually shifted from relatively simple freezing toward higher-concentration cryoprotectant mixtures and attempts at vitrification. This shift reflected genuine developments in low-temperature biology, but it did not turn cryonics into a proven treatment. Historical continuity of storage demonstrates that remains can be maintained at low temperature for many decades; it does not establish that those remains retain the capacity for future revival.

Relationship to cryobiology and established medicine

Cryobiology examines how living systems respond to low temperatures, including chilling injury, ice formation, dehydration, and recovery after warming. Its successful applications are extensive but highly dependent on the biological material involved. Sperm, many embryos, blood-forming cells, and numerous laboratory cell lines can be cryopreserved and subsequently function. These achievements underpin procedures such as in vitro fertilization and hematopoietic stem cell transplantation. They establish that freezing or vitrification need not invariably destroy life, not that every biological structure can already be preserved reversibly.

Scale and organization matter. A small cell suspension can be mixed relatively uniformly with protective chemicals and cooled under controlled conditions. A large organ contains multiple cell types, blood vessels, extracellular structures, and regions with different rates of heat transfer and chemical penetration. A human body adds further complications, including fat, bone, lungs, and organs with incompatible preservation requirements. A method successful for isolated cells may therefore fail when applied to an intact brain or body.

Clinical organ preservation is a related but distinct field. In organ transplantation, a donor organ is maintained for a limited interval before transplantation into a recipient. Conventional cold storage slows deterioration without taking the organ to cryogenic temperatures. Machine perfusion circulates preservation fluids through an organ, sometimes at near-physiological temperatures, to support metabolism or assess function. These techniques have defined clinical endpoints, such as graft function and recipient survival. Cryonics has no demonstrated equivalent endpoint in humans.

Cryonics also differs from medically supervised temperature management after resuscitation. Cooling a living patient within a controlled clinical setting does not involve storing the body in liquid nitrogen. Likewise, accidental survival after profound hypothermia generally involves cooling that occurred before or during circulatory collapse, with subsequent medical resuscitation. Such cases do not demonstrate recovery after prolonged cryogenic storage, concentrated cryoprotectant exposure, or the formation of extensive ice.

Within evidence-based medicine, a proposed intervention is evaluated against specified outcomes and relevant alternatives. Cryonics lacks evidence that its intended outcome—restoration of the preserved individual—can be achieved. Laboratory findings can establish narrower claims, such as reduced ice formation or preservation of recognizable tissue structures. Those findings remain important, but their interpretation depends on the endpoint measured. Anatomical appearance, cellular survival, organ function, and recovery of a person’s memories are different evidential categories.

Procedures from legal death to long-term storage

Cryonics procedures ordinarily begin only after a legally authorized determination of death. Before that point, arrangements may include advance contracts, transport planning, and a standby team near a person expected to die. Such preparations do not authorize the team to cause death or displace ordinary medical care. Their practical purpose is to shorten the interval between legal pronouncement and preservation, although the actual interval depends on location, circumstances of death, access to the body, and legal requirements.

After pronouncement, some protocols use external cooling and mechanical chest compressions to circulate blood or preservation solutions. Although equipment may resemble that used in cardiopulmonary resuscitation, the intended role is different: supporting cooling and chemical distribution rather than providing an established route to recovery. Procedures may also include anticoagulants and other agents intended to limit clotting or postmortem injury. These measures cannot be assumed to restore normal circulation, and their effectiveness depends strongly on the condition of the vasculature.

At a facility equipped for perfusion, blood may be replaced with an organ-preservation solution and then with increasingly concentrated cryoprotectants. Access to major blood vessels requires surgical procedures. Gradual introduction is intended to reduce abrupt osmotic stresses, but achieving a uniform concentration remains difficult. Clotted, damaged, or obstructed vessels can leave regions inadequately protected. A person who dies unexpectedly and remains undiscovered for hours presents very different preservation conditions from someone whose death occurs near an organized standby team.

Providers commonly distinguish whole-body preservation from neuropreservation. In whole-body preservation, the body is retained as the proposed substrate for future repair. Neuropreservation usually means retaining the head, including the brain, rather than preserving an isolated brain alone. Its rationale is that the brain is central to memory and identity, while other body structures might theoretically be replaced or reconstructed. No demonstrated technology can perform the reconstruction required by that rationale.

After perfusion, temperature is lowered through a controlled cooling sequence and eventually toward liquid-nitrogen storage conditions. Procedures vary among organizations and individual cases; preservation is not a uniform event producing a standard biological result. Records of time intervals, temperatures, flow rates, pressures, and perfusate concentrations can document what occurred, but they do not establish eventual reversibility. Some cases receive little or no cryoprotective perfusion because transport delays, autopsy, injury, or other circumstances make the intended protocol impossible.

Ice formation, vitrification, and chemical injury

Water is the principal physical challenge in low-temperature preservation. When extracellular water freezes, ice excludes most dissolved substances, concentrating salts and other solutes in the remaining liquid. Water then moves out of cells, causing dehydration and large changes in cell volume. If cooling is too rapid for adequate water movement, intracellular ice may form. Both routes can damage membranes, proteins, and the organization of tissues. The consequences depend on cooling rate, sample geometry, water permeability, and the composition of the surrounding solution.

Cryoprotectants modify these processes. Substances such as glycerol, dimethyl sulfoxide, and ethylene glycol can reduce ice formation under appropriate conditions. Some enter cells; others act mainly outside them. Their protective effects are accompanied by potential toxicity and osmotic injury. Exposure time, temperature, concentration, and the characteristics of each tissue determine the balance. A concentration that prevents ice is not necessarily compatible with recovery of living cells.

Vitrification is the formation of an amorphous, glass-like solid rather than a crystalline one. In cryobiology, it generally requires a suitable solution and a cooling trajectory that avoids significant ice formation. Concentrated cryoprotectant mixtures reduce the cooling rates needed for vitrification, making larger samples more tractable than they would be with pure water. However, a glass-like state is not equivalent to an undamaged state. Tissue can vitrify after it has already sustained severe ischemic or chemical injury.

The glass transition occurs over a temperature range that depends on the solution. For mixtures relevant to cryopreservation, it is often in the vicinity of −120-120 to −130 ∘C-130\,^\circ\mathrm{C}, although no single temperature applies universally. Below this range, molecular mobility becomes extremely low. Further cooling can introduce mechanical stresses because different parts of a large specimen contract unevenly. Cracks or fractures may develop in vitrified material, particularly where thermal gradients and material constraints are substantial.

Warming introduces another set of hazards. A specimen may form ice during warming even if cooling initially avoided it, a process associated with devitrification and subsequent crystal growth. Uneven warming can combine this problem with thermal stress. Consequently, successful preservation requires more than reaching a low final temperature: the cooling pathway, storage conditions, warming rate, and removal of cryoprotectants must all be compatible with recovery. No complete sequence meeting these requirements has been demonstrated for a cryonically preserved human body or brain.

Ischemia and the preservation of the brain

Cryonics usually starts after circulation has stopped, so preservation begins in tissue already undergoing ischemia, the loss of adequate blood supply. In the brain, interrupted oxygen and glucose delivery reduces production of adenosine triphosphate. Energy-dependent ion pumps fail, electrical gradients deteriorate, and cells swell. Excessive excitatory signaling and calcium entry can contribute to injury. These changes interact with vascular damage, clotting, and the circumstances of the illness or injury that caused death.

The relevant interval is not simply the time between pronouncement and immersion in a cold environment. Injury may begin before legal death during prolonged low blood pressure, inadequate oxygenation, or terminal circulatory instability. Subsequent cooling slows many reactions but does not erase damage already sustained. If circulation is partially re-established during preservation, reperfusion-related processes may also occur. The result is a complex sequence rather than a single moment at which an otherwise normal brain is placed into storage.

Vascular distribution is a major limitation. The blood–brain barrier, vessel condition, tissue swelling, and postmortem changes affect delivery of protective solutions. Good flow through large vessels does not prove uniform perfusion through the smallest vessels. Conversely, a measured concentration in fluid leaving the head does not show that every brain region has reached the same concentration. This makes detailed case-level assessment important when interpreting claims about successful cryoprotection.

The central unresolved issue is what must remain intact for a person’s memories and identity to survive. Memory depends on the organization and functional properties of neural circuits, including synapses, cellular structures, and molecular processes. The hippocampus is particularly important in forming certain kinds of memory, but long-term memory is distributed across networks rather than stored in one isolated structure. A complete account of the physical information sufficient to reconstruct an individual mind does not exist.

Cryonics advocates sometimes use the term information-theoretic death for the hypothetical point at which the information necessary to restore a person has been irretrievably lost. This is a conceptual proposal, not an accepted clinical diagnosis or a validated measurement. Recognizable neurons under a microscope do not establish that all relevant information remains recoverable. Equally, the absence of current function in a cold specimen does not, by itself, reveal exactly which structural information has been retained. Resolving that distinction requires evidence beyond visual preservation alone.

Experimental evidence and its limits

Research relevant to cryonics spans several different endpoints. Investigators may measure cell survival after warming, biochemical activity, electrical responses, preservation of microscopic structure, or the function of a transplanted organ. Each endpoint answers a particular question. Demonstrating one cannot automatically establish another: an enzyme may remain active in tissue that cannot function as an organ, and a well-preserved microscopic image may come from chemically fixed tissue incapable of revival.

One important line of work concerns organ vitrification. In 2023, researchers reported successful transplantation of rat kidneys that had undergone vitrification, storage for as long as 100 days, and rapid rewarming using magnetic nanoparticles. The transplanted kidneys supported life in recipient animals. This was a substantial proof of principle for reversible preservation of a small mammalian organ. It did not demonstrate reversible preservation of a human-sized organ, an entire mammal, or a brain carrying an individual’s memories.

The rewarming method, often called nanowarming, addresses a major scaling problem by generating heat within a specimen rather than relying solely on heat entering from its surface. Magnetic nanoparticles distributed through the preservation solution respond to an alternating magnetic field. The aim is to achieve sufficiently rapid and uniform warming to limit ice formation and thermal damage. Scaling the method requires control over particle distribution, tissue exposure, heat generation, and subsequent removal of preservation materials.

Another research direction is aldehyde-stabilized cryopreservation. Work published in 2015 and appearing in a 2016 journal issue demonstrated excellent ultrastructural preservation in rabbit brain tissue using chemical fixation followed by cryogenic preservation. Aldehyde fixation cross-links biological molecules and can preserve fine anatomical detail, but it does not preserve living tissue in the ordinary reversible sense. Such studies are relevant to structural mapping and proposed information-preservation criteria, not evidence that a fixed brain can be restarted.

There has been no demonstrated revival of a cryonically preserved person or recovery of an intact adult mammal after the full sequence used in human cryonics. Proposed future methods include molecular-scale repair, tissue regeneration, and computational reconstruction of neural organization. None supplies an established repair pathway for a stored human brain. The scientific gap is therefore not merely an engineering detail awaiting routine implementation: the required repair capabilities, the adequacy of preserved information, and the criteria for restored personal continuity all remain unresolved.

Storage engineering and institutional continuity

Long-term cryonic storage commonly uses liquid nitrogen at approximately −196 ∘C-196\,^\circ\mathrm{C} under ordinary atmospheric pressure. Liquid nitrogen boils as it absorbs heat from the surroundings, maintaining a low temperature while sufficient liquid remains. Storage vessels are generally vacuum-insulated containers, often called Dewars. Their insulation reduces heat entry but cannot eliminate it, so nitrogen must be replenished periodically. Cryogenic storage is an ongoing maintenance process, not a one-time act of cooling.

Many such storage vessels do not require electrically powered refrigeration to maintain temperature directly. This distinguishes them from freezers that warm rapidly when power fails. Nevertheless, a facility still depends on monitoring, staff, supply deliveries, building access, and organizational coordination. A prolonged interruption in nitrogen supply, unnoticed leakage, or loss of custody can threaten preservation. Power failures can also affect alarms, communications, ventilation, and the surrounding infrastructure even when the vessel itself remains cold.

Storage risks include mechanical damage, fire affecting the facility, flooding, earthquakes, equipment failure, and human error. Liquid nitrogen also creates occupational hazards: very cold surfaces can cause cold injuries, and evaporating nitrogen can displace oxygen in enclosed spaces. Engineering controls and monitoring are therefore relevant both to preservation and to staff safety. Tank temperature alone is not a complete measure of facility resilience.

The exceptionally long proposed storage period makes institutional survival a biological concern. An organization must retain legal control of remains, maintain records, secure supplies, and preserve sufficient financial resources across leadership changes and economic disruptions. Contracts and dedicated funds attempt to separate continuing storage obligations from ordinary operating expenses, but no financial structure can guarantee indefinite continuity. Inflation, changes in law, litigation, and the disappearance of service providers are uncertainties distinct from tissue damage.

Documentation has a similarly long time horizon. Medical records, preservation logs, identity information, and custody records may be needed if future examination becomes possible. The survival of a storage vessel without reliable documentation could create problems of identification and interpretation. Conversely, excellent records cannot compensate for loss of biological material. Cryonics therefore depends on maintaining both physical custody and information stewardship, with failure possible in either system independently.

Death, legal status, and consent

Cryonics operates within legal systems that determine when medical responsibility ends and control over human remains begins. Legal death is not identical to the instantaneous death of every cell. After circulation ceases, different tissues lose viability at different rates. This biological unevenness does not remove the legal distinction between a living patient and a deceased person. It explains why some cells or organs can remain usable after death without establishing that the person as a whole can be recovered.

In many jurisdictions, death may be determined through circulatory criteria or neurological criteria under applicable law and clinical standards. Brain death is a medical and legal determination based on the permanent loss of brain function under specified conditions; it is not a label for every instance of cardiac arrest. Most planned cryonics arrangements involve preservation after death determined on circulatory grounds, but actual circumstances vary. Cryonics providers do not possess a separate authority to redefine legal death.

Authorization for preservation may involve anatomical-gift law, rules governing human remains, contracts, and directions concerning disposition. The applicable framework differs by jurisdiction. A signed agreement does not necessarily override a coroner’s investigation, a required autopsy, infectious-disease controls, or transport rules. An autopsy can substantially disrupt structures that a preservation procedure seeks to retain. International transport adds requirements for documentation, custody, and compliance with more than one legal system.

The 2016 English case Re JS (Disposal of Body) concerned a terminally ill 14-year-old who wished to undergo cryonic preservation. The court addressed who should have authority over the arrangements following her death amid disagreement between her parents. It did not rule that cryonics was scientifically effective. The distinction is important: a legal decision permitting a form of disposition is not a medical endorsement of its underlying claims.

Valid authorization also raises questions about understanding and decision-making capacity. The anticipated benefit depends on technologies that do not currently exist, and a probability of successful revival cannot be established from observed human outcomes. Agreements may address storage obligations, termination, and transfer of remains, but they cannot confer a presently recognized right to future resurrection. Nor do they settle hypothetical questions about citizenship, property, family relationships, or legal identity if revival were ever achieved.

Ethical and social questions

The central ethical distinction is between allowing individuals to choose an unconventional disposition of their remains and presenting that disposition as an effective treatment. Respect for personal choice does not establish scientific efficacy. Accurate disclosure must distinguish demonstrated capabilities—such as maintaining very low temperatures—from speculative claims about repairing a brain and restoring the same person. This distinction becomes especially important when arrangements are discussed during terminal illness or family distress.

Cryonics can intersect with end-of-life care because rapid postmortem access and preservation logistics may influence where a person wishes to spend their final days. Those preferences can coexist with ordinary symptom relief and palliative care, but they may also create practical disagreements about transport, access, or the handling of the body. Decisions made while a person is alive remain governed by the standards applicable to living patients, rather than by the needs of a future preservation procedure.

Personal identity poses a further problem. Restoring biological activity would not necessarily establish the recovery of memory, personality, or continuity of consciousness. Conversely, a hypothetical computational reconstruction reproducing a person’s behavior would raise different questions from repairing the original brain. Philosophical accounts disagree over the relative importance of bodily continuity, psychological continuity, and causal connection. These are not questions that a low storage temperature or an anatomical scan can independently resolve.

Access is shaped by cost, geography, and organizational availability. Some arrangements are funded through life insurance rather than payment of the entire storage charge during life, but standby services, transport, and case complications can add substantial expenses. Comparisons of advertised prices are difficult because services and financial arrangements differ. Discussion of fairness therefore concerns both who can obtain preservation and how uncertain benefits are represented, rather than an established allocation of a life-saving treatment.

Cryonics also creates unusual obligations toward people who cannot monitor, revise, or enforce their arrangements after death. Providers and custodians may hold responsibilities extending far beyond the lives of the original contracting parties. Family members may have different views about mourning, burial, memorialization, and continued expenditure. These obligations remain concrete even though revival is hypothetical: they concern custody of remains, truthful records, use of entrusted funds, and the conditions under which preservation might be transferred or discontinued.